Important: A national shortage record does not tell you whether a particular pharmacy has stock. Local availability, product presentation, wholesaler supply, prescription status and insurance rules can differ. Check the FDA Drug Shortages page and ask a pharmacist about current local supply.
What the public records show
The table reports the result of a dated query of the FDA openFDA drug shortages dataset. “No matching current record returned” is deliberately narrower than saying a medicine is available everywhere.
| Active ingredient | Snapshot result | Record detail | What it does not prove |
|---|---|---|---|
| Semaglutide | No matching current record returned | No semaglutide shortage record appeared in the selected FDA dataset query on August 22, 2026. | It does not prove every semaglutide product or pharmacy has stock. |
| Tirzepatide | No matching current record returned | No tirzepatide shortage record appeared in the selected FDA dataset query on August 22, 2026. | It does not confirm a product, dose, pharmacy or insurance route. |
| Dulaglutide | No matching current record returned | No dulaglutide shortage record appeared in the selected FDA dataset query on August 22, 2026. | It does not establish local supply or access. |
| Liraglutide | Records marked Available | Current records included several manufacturers and product presentations, with updates through August 17, 2026. | It does not guarantee local stock or suitability for an individual. |
How to read this tracker
- Start with the exact product. An active ingredient can appear in more than one brand, formulation, presentation or manufacturer record.
- Separate national status from local stock. FDA shortage data tracks national supply conditions. Pharmacies can have temporary local shortages or supply before a national record changes.
- Check the date. The page is a snapshot. The FDA database can change after this page is published.
- Use a pharmacist or prescriber for next steps. If a prescribed product is unavailable, ask them about the situation and options for your care. Do not ration, substitute or change a prescription based only on this table.
Methodology
ThinkGLP queried the FDA openFDA drug shortages dataset for records containing semaglutide, tirzepatide, dulaglutide or liraglutide and reviewed the returned generic name, availability, status, manufacturer, presentation and update date. We report the result as a dated public-data snapshot. We do not infer a national “in stock” guarantee from an empty query result, and we do not rank products or recommend treatment.
Sources
- FDA Drug Shortages, including the live shortage database.
- openFDA Drug Shortages API documentation.
- openFDA Drug Shortages download information.
- ThinkGLP GLP-1 updates log for related public access changes.
Frequently asked questions
Does the FDA tracker show whether my pharmacy has a GLP-1 in stock?
No. FDA shortage data is national-level information and does not confirm inventory at a particular pharmacy, wholesaler or clinic. A local stock issue can exist even when a product is not listed as nationally in shortage.
What does available mean in the tracker?
Available is the availability value shown in the FDA record for the listed product and manufacturer. It is not a guarantee of local inventory, insurance coverage or personal access.
How often is this GLP-1 availability tracker updated?
ThinkGLP records a dated snapshot from the FDA public dataset and links to the live FDA shortage database. The source can change after our snapshot, so readers should check the FDA database and ask a pharmacist about current local supply.
What should I do if my prescribed GLP-1 is unavailable?
Ask the prescriber or pharmacist about the current supply situation and appropriate options for your care. Do not change, ration or substitute a prescription based only on a shortage table.